Clinical Trials
7 trialsNCT04564157 2026-05-05
NADIM-ADJUVANT
Fundación GECP
Phase 3 Active not recruiting
NCT07247786 2026-05-05
MIGRANT
Fundación GECP
Phase 2 Not yet recruiting
NCT04222972 2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3 Terminated
NCT06917573 2025-11-19
PALACE
Fundación GECP
Phase 2 Recruiting
NCT04776447 2025-04-09
APOLO
Fundación GECP
Phase 2 Active not recruiting
NCT02826161 2023-11-15
CanStem43L
Sumitomo Pharma America, Inc.
Phase 3 Terminated
NCT01199055 2020-07-07
CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)
Daiichi Sankyo
Phase 1 Completed